Fig. 5. Flow cytometry of the BCSCs and immunological
markers . A. Histograms of flow cytometric analysis of CSCs
markers; CD44, CD24, and SCa-1 as well as immune cells markers; CD117,
CD62L, and CD4. Blood samples were collected from mice in the SEC/CDDP
groups. B. One-way ANOVA was done (n = 5). Data are expressed
as mean ± SD. * p < 0.05, ** p < 0.01,
*** p < 0.001, ns = nonsignificant. BCSCs: breast
cancer stem cells, CD: cluster of differentiation, SCa-1: stem cell
antigen 1, SEC: solid Ehrlich carcinoma, SEC/CDDP: cisplatin-resistant
SEC, SEC/CDDP-CDDP: cisplatin-resistant SEC treated with cisplatin,
SEC/CDDP-indomethacin: cisplatin-resistant SEC treated with
indomethacin, SEC/CDDP-combination: cisplatin-resistant SEC treated with
CDDP and indomethacin.